Literature DB >> 25194694

The Role of Mast Cells in Molding the Tumor Microenvironment.

A Rigoni1, M P Colombo2, C Pucillo3.   

Abstract

Mast cells (MCs) are granulocytic immune cells that reside in tissues exposed to the external environment. MCs are best known for their activity in allergic reactions, but they have been involved in different physiological and pathological conditions. In particular, MC infiltration has been shown in several types of human tumors and in animal cancer models. Nevertheless, the role of MCs in the tumor microenvironment is still debated because they have been associated either to good or poor prognosis depending on tumor type and tissue localization. This dichotomous role relies on MC capacity to secrete a broad spectrum of molecules with modulatory functions, which may condition the final tumor outcome also promoting angiogenesis and tissue remodeling. In this review, we analyze the multifaceted role of mast cell in tumor progression and inhibition considering their ability to interact with: i) immune cells, ii) tumor cells and iii) the extracellular matrix. Eventually, the current MC targeting strategies to treat cancer patients are discussed. Deciphering the actual role of MCs in tumor onset and progression is crucial to identify MC-targeted treatments aimed at killing cancer cells or at making the tumor vulnerable to selected anti-cancer drugs.

Entities:  

Keywords:  Cancer; Extracellular matrix; Immune responses; Immunosuppression; Mast cell

Year:  2014        PMID: 25194694      PMCID: PMC4715001          DOI: 10.1007/s12307-014-0152-8

Source DB:  PubMed          Journal:  Cancer Microenviron        ISSN: 1875-2284


  95 in total

Review 1.  Review article: colorectal carcinoma and inflammatory bowel disease.

Authors:  J Eaden
Journal:  Aliment Pharmacol Ther       Date:  2004-10       Impact factor: 8.171

2.  Macrophage and mast-cell invasion of tumor cell islets confers a marked survival advantage in non-small-cell lung cancer.

Authors:  Tomas J Welsh; Ruth H Green; Donna Richardson; David A Waller; Kenneth J O'Byrne; Peter Bradding
Journal:  J Clin Oncol       Date:  2005-10-11       Impact factor: 44.544

3.  Aryl hydrocarbon receptor-induced signals up-regulate IL-22 production and inhibit inflammation in the gastrointestinal tract.

Authors:  Ivan Monteleone; Angelamaria Rizzo; Massimiliano Sarra; Giuseppe Sica; Pierpaolo Sileri; Livia Biancone; Thomas T MacDonald; Francesco Pallone; Giovanni Monteleone
Journal:  Gastroenterology       Date:  2011-04-16       Impact factor: 22.682

4.  Mast cells are novel independent prognostic markers in prostate cancer and represent a target for therapy.

Authors:  Anna Johansson; Stina Rudolfsson; Peter Hammarsten; Sofia Halin; Kristian Pietras; Jonathan Jones; Pär Stattin; Lars Egevad; Torvald Granfors; Pernilla Wikström; Anders Bergh
Journal:  Am J Pathol       Date:  2010-07-08       Impact factor: 4.307

5.  Mast cell 5-lipoxygenase activity promotes intestinal polyposis in APCDelta468 mice.

Authors:  Eric C Cheon; Khashayarsha Khazaie; Mohammad W Khan; Matthew J Strouch; Seth B Krantz; Joseph Phillips; Nichole R Blatner; Laura M Hix; Ming Zhang; Kristen L Dennis; Mohammed R Salabat; Michael Heiferman; Paul J Grippo; Hidayatullah G Munshi; Elias Gounaris; David J Bentrem
Journal:  Cancer Res       Date:  2011-01-07       Impact factor: 12.701

6.  Evidence questioning cromolyn's effectiveness and selectivity as a 'mast cell stabilizer' in mice.

Authors:  Tatsuya Oka; Janet Kalesnikoff; Philipp Starkl; Mindy Tsai; Stephen J Galli
Journal:  Lab Invest       Date:  2012-08-20       Impact factor: 5.662

7.  T-regulatory cells shift from a protective anti-inflammatory to a cancer-promoting proinflammatory phenotype in polyposis.

Authors:  Elias Gounaris; Nichole R Blatner; Kristen Dennis; Fay Magnusson; Michael F Gurish; Terry B Strom; Philipp Beckhove; Fotini Gounari; Khashayarsha Khazaie
Journal:  Cancer Res       Date:  2009-07-01       Impact factor: 12.701

8.  IL4Ralpha+ myeloid-derived suppressor cell expansion in cancer patients.

Authors:  Susanna Mandruzzato; Samantha Solito; Erika Falisi; Samuela Francescato; Vanna Chiarion-Sileni; Simone Mocellin; Antonio Zanon; Carlo R Rossi; Donato Nitti; Vincenzo Bronte; Paola Zanovello
Journal:  J Immunol       Date:  2009-05-15       Impact factor: 5.422

9.  Aryl hydrocarbon receptor plays a significant role in mediating airborne particulate-induced carcinogenesis in mice.

Authors:  Yutaka Matsumoto; Fumio Ide; Reiko Kishi; Tomoko Akutagawa; Shigekatsu Sakai; Masafumi Nakamura; Toshitaka Ishikawa; Yoshiaki Fujii-Kuriyama; Yoko Nakatsuru
Journal:  Environ Sci Technol       Date:  2007-05-15       Impact factor: 9.028

10.  High density of tryptase-positive mast cells in human colorectal cancer: a poor prognostic factor related to protease-activated receptor 2 expression.

Authors:  Andrea Malfettone; Nicola Silvestris; Concetta Saponaro; Girolamo Ranieri; Antonio Russo; Stefano Caruso; Ondina Popescu; Giovanni Simone; Angelo Paradiso; Anita Mangia
Journal:  J Cell Mol Med       Date:  2013-08       Impact factor: 5.310

View more
  27 in total

1.  Tumor stroma-infiltrating mast cells predict prognosis and adjuvant chemotherapeutic benefits in patients with muscle invasive bladder cancer.

Authors:  Zheng Liu; Yu Zhu; Le Xu; Junyu Zhang; Huyang Xie; Hangcheng Fu; Quan Zhou; Yuan Chang; Bo Dai; Jiejie Xu
Journal:  Oncoimmunology       Date:  2018-08-01       Impact factor: 8.110

2.  Vascular alterations after photodynamic therapy mediated by 5-aminolevulinic acid in oral leukoplakia.

Authors:  Flávia Cristina Perillo Rosin; Ana Rita Ribeiro Barcessat; Giuliana Gadoni Giovanni Borges; Luciana Gonçalves Valente Ferreira; Luciana Corrêa
Journal:  Lasers Med Sci       Date:  2016-12-21       Impact factor: 3.161

Review 3.  Histamine receptors and cancer pharmacology: an update.

Authors:  Noelia A Massari; Melisa B Nicoud; Vanina A Medina
Journal:  Br J Pharmacol       Date:  2018-12-13       Impact factor: 8.739

4.  Targeting tumor-resident mast cells for effective anti-melanoma immune responses.

Authors:  Susanne Kaesler; Florian Wölbing; Wolfgang Eberhard Kempf; Yuliya Skabytska; Martin Köberle; Thomas Volz; Tobias Sinnberg; Teresa Amaral; Sigrid Möckel; Amir Yazdi; Gisela Metzler; Martin Schaller; Karin Hartmann; Benjamin Weide; Claus Garbe; Hans-Georg Rammensee; Martin Röcken; Tilo Biedermann
Journal:  JCI Insight       Date:  2019-10-03

5.  Epigenetic promoter alterations in GI tumour immune-editing and resistance to immune checkpoint inhibition.

Authors:  Kie-Kyon Huang; Vikrant Kumar; Kalpana Ramnarayanan; Deniz Demircioglu; Zhisheng Her; Raghav Sundar; Xuewen Ong; Zul Fazreen Bin Adam Isa; Manjie Xing; Angie Lay-Keng Tan; David Wai Meng Tai; Su Pin Choo; Weiwei Zhai; Jia Qi Lim; Meghna Das Thakur; Luciana Molinero; Edward Cha; Marcella Fasso; Monica Niger; Filippo Pietrantonio; Jeeyun Lee; Anand D Jeyasekharan; Aditi Qamra; Radhika Patnala; Arne Fabritius; Mark De Simone; Joe Yeong; Cedric Chuan Young Ng; Sun Young Rha; Yukiya Narita; Kei Muro; Yu Amanda Guo; Anders Jacobsen Skanderup; Jimmy Bok Yan So; Wei Peng Yong; Qingfeng Chen; Jonathan Göke; Patrick Tan
Journal:  Gut       Date:  2021-08-25       Impact factor: 31.793

6.  CXCL3 Signaling in the Tumor Microenvironment.

Authors:  Niradiz Reyes; Stephanie Figueroa; Raj Tiwari; Jan Geliebter
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 7.  Redirecting tumor-associated macrophages to become tumoricidal effectors as a novel strategy for cancer therapy.

Authors:  Xiang Zheng; Kati Turkowski; Javier Mora; Bernhard Brüne; Werner Seeger; Andreas Weigert; Rajkumar Savai
Journal:  Oncotarget       Date:  2017-07-18

8.  Live Staphylococcus aureus Induces Expression and Release of Vascular Endothelial Growth Factor in Terminally Differentiated Mouse Mast Cells.

Authors:  Carl-Fredrik Johnzon; Elin Rönnberg; Bengt Guss; Gunnar Pejler
Journal:  Front Immunol       Date:  2016-06-23       Impact factor: 7.561

9.  Class A1 scavenger receptor modulates glioma progression by regulating M2-like tumor-associated macrophage polarization.

Authors:  Hanwen Zhang; Wenbin Zhang; Xuan Sun; Ruoyu Dang; Rongmei Zhou; Hui Bai; Jingjing Ben; Xudong Zhu; Yan Zhang; Qing Yang; Yong Xu; Qi Chen
Journal:  Oncotarget       Date:  2016-08-02

Review 10.  The interplay between mast cells, pineal gland, and circadian rhythm: Links between histamine, melatonin, and inflammatory mediators.

Authors:  Linh Pham; Leonardo Baiocchi; Lindsey Kennedy; Keisaku Sato; Vik Meadows; Fanyin Meng; Chiung-Kuei Huang; Debjyoti Kundu; Tianhao Zhou; Lixian Chen; Gianfranco Alpini; Heather Francis
Journal:  J Pineal Res       Date:  2020-11-29       Impact factor: 12.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.